Topical Bevacizumab for Preventing Recurrent Pterygium

Summary

The purpose of this study is to determine whether bevacizumab eye drop is effective in the treatment of recurrent pterygium.

Timeline

Start

2010-12

Primary completion

2013-03

Completion

2013-04

Outcome

Missed primary endpoint

paper No significant (P = 0.293) differences were found between the groups as determined by Fisher's exact test. PMID 26409291 ↗

Publications

• Kasetsuwan N, Reinprayoon U, Satitpitakul V. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial. Clin Ther. 2015 Oct 1;37(10):2347-51. doi: 10.1016/j.clinthera.2015.08.023. Epub 2015 Sep 26.

Drugs

Indications